Researcher Spotlight: Phil Lange, PhD
Dr. Lange is a Postdoctoral Fellow at UNC Lineberger Comprehensive Cancer Center in Chapel Hill, N.C, where he is mentored by Dr. Blossom Damania.
Tag non-hodgkin lymphoma
Elena Battistello, PhD
Researcher Spotlight: Elena Battistello, PhD New York University School of Medicine Peripheral T-cell lymphoma (PTCL) is an aggressive type of non-Hodgkin lymphoma (NHL) derived from the malignant transformation of blood cells called T-lymphocytes. Currently, patients diagnosed with PTCL have limited…
Xu Cao, PhD
Researcher Spotlight: Xu Cao, PhD City of Hope and Beckman Research Institute Many types of non-Hodgkin lymphoma (NHL) remain incurable due to its intrinsic genomic instability facilitating the escape from cytotoxic or targeted therapies. “Recent breakthroughs in understanding macrophage-mediated immune…
Alexia Martinez de Paz, PhD
Researcher Spotlight: Alexia Martinez de Paz, PhD Joan & Sanford I. Weill Medical College of Cornell University Cell-fate transitions (a biological process in which the function of a cell gets specialized, reprogrammed, or altered) during the germinal center (GC) reaction…
Ryan Lynch, MD
Researcher Spotlight: Ryan Lynch, MD University of Washington Checkpoint inhibitors, a type of immunotherapy, have been approved for patients with relapsed Hodgkin lymphoma (HL); however, they do not lead to durable remissions in most patients. Dr. Lynch’s LRF grant project…
Adam Lin, MD, PhD
Researcher Spotlight: Adam Lin, MD, PhD Northwestern University Feinberg School of Medicine Many immunotherapies and cell therapies on the market have increased the cure rate for patients with non-Hodgkin lymphoma (NHL); however, the percentage of relapse and death continues to…
Yazeed Sawalha, MD
Researcher Spotlight: Yazeed Sawalha, MD Cleveland Clinic Patients with indolent non-Hodgkin lymphoma who relapse or have refractory lymphoma that does not respond to treatment still have poorer outcomes, with many of the current available treatments having either limited benefit or significant side effects.…
Reem Karmali, MD, MS
Researcher Spotlight: Reem Karmali, MD, MS Rush University Dr. Karmali is an Assistant Professor at Rush University Medical Center. Her LRF Clinical Research Mentoring Program (LCRMP) project investigates a process known as cancer cachexia, a metabolic syndrome that causes…